Andy Whittle, VP Manufacturing at QuantuMDx, discusses the highs and lows of scaling up to manufacture, during a global pandemic. What is your background? I’ve over 20 years manufacturing experience,
ContinueOur Head of Assay Feasibility, Dr John Tyson presented an e-poster at ECCVID last month – the ESCMID Conference on Coronavirus. The e-poster focuses on the independent, multi centre, clinical performance
ContinueSam Bhatt is a Programme Manager at QuantuMDx. Here, Sam tells us more about himself and gives us an insight into his role. When did you start working at QuantuMDx?
ContinueIsbelis Lopez is a KTP Associate at QuantuMDx. Here, she tells us more about her role. When did you know you wanted to be a scientist and why? Growing up
ContinueWhat is Antimicrobial Resistance? One of the biggest misconceptions is that we’re becoming resistant to antibiotics. In fact, it’s bacteria that are becoming resistant to antibiotics. Antimicrobial Resistance (AMR) develops
ContinuePaul Steele, Senior QA/RA Officer, gives us an insight into his role. When did you know you wanted to work in Quality Assurance and why? It was probably back when I
ContinueThis month Heather Murton, Head of Clinical Assay, is giving us the lowdown on her role. When did you know you wanted to be a scientist and why? By
ContinueQuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (C>s), to be evaluated
ContinueThis month we’re chatting to Marc Flanagan and getting an insight into his role as Senior Scientist at QuantuMDx. What does your role involve? I’m a Senior Scientist in the
ContinueQuantuMDx is an member of the Stop TB Partnership Private Sector Constituency (PSC) and on World TB Day (24th March), we’re coming together to highlight the devastating health, social, and
ContinueThis month we find out more about Nerea Plaza and her role as a Mechanical Engineer at QuantuMDx. When did you know you wanted to be a engineer and
ContinueTo coincide with Cervical Cancer Prevention Week, QuantuMDx Group has announced the start of a field study with St George’s, University of London, to evaluate its human papilloma virus (HPV)
ContinueTo mark the start of Cervical Cancer Prevention Week, we’ve devised an infographic to outline the burden of cervical cancer in low and middle income countries and highlight the need
ContinueUnder the spotlight this month it’s Jonathan Peat, VP Business Development, giving us an insight into his role and career highlights. When did you know you wanted to be
ContinueIn February last year we announced a partnership with Intellectual Ventures’ Global Good fund, to develop a test to support cervical cancer screening in low- and middle-income countries (LMICs). We are jointly developing
ContinueNext week, world leaders will meet to take part in the first UN High Level Meeting on TB, in history. As QuantuMDx is the only UK company accredited to attend
ContinueTo celebrate our 10th birthday this year, we’ve produced an infographic to chart our incredible journey, from a makeshift laboratory in a Sussex garage, to performance testing of our Q-POC™
ContinueWe’re launching a new ‘Staff Spotlight’ feature: a Q&A with members of Team QuantuMDx to gain an insight into their role, career highlights and ambitions. This month we’ve interviewed Jennifer
ContinueTo coincide with World TB Day, Mark Ware, Patient Engagement and Training Manager at QuantuMDx, highlights the importance of end user engagement when devising point of care diagnostic tools for infectious
ContinueWe’re on the precipice of achieving truly monumental strides for gender equality. Progress has been made in recent years to achieve gender equality for women globally; in 46 countries women
ContinueAda Lovelace Day is an international day in celebration of the achievements of women in Science, Technology, Engineering, and Maths (STEM). The day aims to increase the profile of women
ContinueSuperbugs – infections that have developed resistance to some, or all antibiotics – could kill 10 million people a year by 2050, Lord Jim O’Neill has warned in his final
ContinueBuilding on the achievements of the Millennium Development Goals, World Malaria Day this year is exploring ways to ‘End Malaria for Good’. The theme is focusing on the recently launched
Continue
In celebration of International Women’s Day (8th March), and this year’s theme ‘Pledge for Parity’, we are exploring how to help women and girls achieve their ambitions. As part of
ContinueDrop by our stand at Hall 1 D21 to see for yourself how easy running a 20 minute molecular diagnostic test will be with handheld device Q-POC, or learn more
Continue“The world is a funny place; we know the problem with antimicrobial resistance and we know we have the tools to address it, across different disciplines, fields & industries, but
Continue
As you will have seen over the past few months the QuantuMDx family has been growing quickly. To accommodate all the current and future Quantumites we’re moving to brand new,
ContinueDuring his latest trip to Cape Town, our CSO Jonathan O’Halloran met with Dr Javid Abdelmoneim to discuss Q-POC and its role in the fight against antibiotic resistance.
ContinueSix weeks ago QuantuMDx produced a prototype handheld molecular diagnostic device that will provide a DNA-based diagnostic and drug resistance test result in less than half an hour. This milestone
ContinueOur Chief Scientific Officer Jonathan O’Halloran recently contributed to the Review on Antimicrobial Resistance report published last Friday. The review, led by Jim O’Neill, sets out proposals to transform antibiotic use
ContinueEmpowering Healthworkers, Globally You’ve been awake all night with your youngest. He has a fever. Morning has broken, so you bundle him up and make your way across to see
ContinueWe’ve been preparing for it all year, and now Medica is finally upon us! We will be bringing along some Q-POC demos, giving you the opportunity to run through a
ContinueLooking back on 2014, we’ve come a long way baby! We made great strides in the development of our handheld MDx device Q-POC™, effectively transitioning from an R&D organization to
ContinueOur COO Dr Sam Whitehouse recently met with Moira Gunn from Biotech Nation on NPR to discuss our latest developments with Q-POC™ and the impact the device will have on
Continue
